Drug News

Medindia's Press Release’ section provides the latest press release on Drug from across the world for the global audience. This page links to 12884 Drug press releases.

The Atrial Fibrillation Drug Market Will Increase More Than Sevenfold, from $790 Million in 2008 to $6.1 Billion in 2018

WALTHAM, Mass., Dec. 14 Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, owing to the launches of several new agents, the atrial fibrillation drug market ...


Manchester Announces Availability of Chenodal(TM)

FORT COLLINS, Colo., Dec. 14 Manchester Pharmaceuticals, Inc.(TM) announced today the availability of Chenodal(TM) 250 mg (chenodiol tablets). On October 22, 2009, the US Food and Drug Administration (FDA) approved Chenodal, an ...

ED Product Caverta 100 mg manufactured by Ranbaxy, from a licensed pharmacy

Caverta is a quite a popular drug which is used to treat problems related to impotency in men and can help improve their sex lives to a great extent. Launched by Ranbaxy it is very much similar to Viagra and contains active ingredients used for ...

Drenchers(R) Immunity Now Flavored With Pomegranate

ORLANDO, Fla., Dec. 10 In its ever-continuing quest to provide consumers with the most delicious and nutritious beverages on the planet, Drenchers® has improved its all natural 100 percent super juice, Immunity, and Fit 'N Lean Immunity by ...

Published Data Demonstrate Arena Pharmaceuticals' Lorcaserin Has Low Abuse Potential

SAN DIEGO, Dec. 10, 2009 Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) reported that positive data from a clinical trial evaluating the abuse potential of lorcaserin were presented in a poster session at the 48th Annual Meeting of the ...

Cumberland Pharmaceuticals Licenses Caldolor(R) (ibuprofen) Injection to DB Pharm Korea for Commercialization in South Korea

Nashville, Tenn. , Dec. 9 /PRNewswire-FirstCall/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) today announced that it has entered into an exclusive agreement with DB Pharm Korea Co. Ltd. , a Korean-based pharmaceutical company, for ...

Statement of HDMA President and CEO John M. Gray on the Importation of Prescription Drugs

ARLINGTON, Va. , Dec. 9 /PRNewswire-USNewswire/ -- John M. Gray , President and Chief Executive Officer of the Healthcare Distribution Management Association (HDMA), issued the following statement in reaction to Senate Amendment 2793 to the ...

Reportlinker Adds Training Manikins - Global Trends

NEW YORK, Dec. 8 Reportlinker.com announces that a new market research report is available in its catalogue: Training Manikins - Global Trends http:www.reportlinker.com/p0164290/Training-Manikins---Global-Trends.html ...

Statement By Jim O'Hara, Director, Produce Safety Project, in Response to the FDA's Announcement on Enforceable Standards for Fresh Produce Safety

WASHINGTON, Dec. 8 The Food and Drug Administration's announcement that it plans to issue proposed regulations for fresh produce safety by October 2010 is a significant public health victory for American families and farmers. By ...

Reportlinker Adds Pharmacodynamic Assays

NEW YORK, Dec. 8 Reportlinker.com announces that a new market research report is available in its catalogue: Pharmacodynamic Assays http:www.reportlinker.com/p0167260/Pharmacodynamic-Assays.html Pharmacodynamic assays are ...

Drug News »

Stomach Paralysis Risk Found in Users of Weight Loss Drugs

Stomach Paralysis Risk Found in Users of Weight Loss Drugs

In a concerning revelation, the utilization of popular diabetes and weight loss drugs has been associated with an elevated risk of stomach paralysis, a rare yet severe condition known as gastroparesis . Emerging from comprehensive ...

 Semaglutide's Multifaceted Benefits in Diabetes Treatment

Semaglutide's Multifaceted Benefits in Diabetes Treatment

Semaglutide , as highlighted by a groundbreaking study, offers substantial benefits by reducing the risk of major kidney disease events, cardiovascular outcomes, and all-cause mortality in patients diagnosed with type 2 diabetes and chronic kidney disease ( )....

From Pandemic to Poultry: COVID Shot Tech Targets H5N1 Bird Flu

From Pandemic to Poultry: COVID Shot Tech Targets H5N1 Bird Flu

In response to the worldwide surge in H5N1 cases, American researchers have created an experimental mRNA vaccine , leveraging COVID-19 vaccine technology, to combat avian flu infections ( ). Preclinical models, detailed in the journal Nature ...

Diabetes and Obesity Market of GLP-1 Drugs Will Be $125 Billion By 2033!

Diabetes and Obesity Market of GLP-1 Drugs Will Be $125 Billion By 2033!

The type 2 diabetes and obesity market for GLP-1R agonists is expected to reach $125 billion in 7 major markets by 2033. This estimation has been projected by GlobalData, a leading data and analytics company ( ). Glucagon-like ...

Blood Pressure Drugs Double Bone-Fracture Risk

Blood Pressure Drugs Double Bone-Fracture Risk

Blood pressure medications significantly elevate the risk of life-threatening bone fractures, as per research by Rutgers Health published in JAMA Internal Medicine. The...

More Drug News

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.